QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.
QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. We develop these antibodies using the client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. We are a full-service corporation, and offer additional immunochemistry services such as purification and conjugation so that we can provide our clients with an antibody product that will work specifically within their system. We also develop monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.
QED offers the most cost effective means of producing large quantities of monoclonal antibodies in vitro. Your hybridoma cell lines are grown in our MAb production medium that is designed to enhance antibody production 5-25X above the levels obtained in conventional media, providing you with more antibody for your research dollar.
Read about the performance of multiple different cell lines in our MAb production medium. View PDF
All programs can be customized to fit your needs, so if you need additional rabbits or want to use your own immunization protocol, just send us your requirements – we’ll be happy to send you a price quote for your project.
ELISA titration of each bleed when collected |
Terminal immunization and bleed |
Onsite or same day tissues delivery |
Affinity chromatography purification (Protein A, G, Antigen) |
PEG Precipitation |
Cell culture services |